FASTinov proudly announces its recent participation alongside Quilaban at the XIII edition of the esteemed Portuguese National Clinical Pathology Congress.
Read More...May the new year bring you peace, good health, and success as we embark on a new chapter of groundbreaking medical advancements.
Read More...FASTinov and Quilaban are thrilled to announce the formal launch of the distribution of FASTinov's cutting-edge products through Quilaban.
Read More...FASTinov announces the appointment of Mr. George Skinner as Director of Commercial Operations of FASTinov.
Read More...FASTinov announces that the prestigious oncology hospital IPO Porto has chosen to introduce its cutting-edge AST technology into its healthcare infrastructure.
Read More...FASTinov announces the publication of groundbreaking data from the very first customer evaluations of its FASTinov® technology.
Read More...
© 2022 FASTinov S.A. - All Rights Reserved - Webdesign by Nova Agência